Neuland Laboratories Share Price
22830.00-60.00 (-0.26%)
+58.89% past 1 Year
Neuland Laboratories is a leading global API contract development and manufacturing organization (CDMO). It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex active pharmaceutical ingredients
Corporate filings & documents
Announcements
Announcement under Regulation 30 (LODR) - Credit Rating
1 week agoAnnouncement under Regulation 30 (LODR) - Credit Rating
1 week agoCopy of Newspaper Publication
1 week agoCopy of Newspaper Publication
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Malabar India Fund Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Malabar India Fund Ltd
2 weeks agoIntimation regarding completion of US FDA Inspection
2 weeks agoIntimation regarding completion of US FDA Inspection
2 weeks agoTranscript of the Earnings Call conducted on August 5 2026
3 weeks agoTranscript of the Earnings Call conducted on August 5 2026
3 weeks agoIntimation about Schedule of Analyst / Institutional Investor Meeting on August 12 2026
3 weeks agoIntimation about Schedule of Analyst / Institutional Investor Meeting on August 12 2026
3 weeks agoCopy of Newspaper Publication
4 weeks agoCopy of Newspaper Publication
4 weeks agoAudio Recording of the Earnings call conducted on August 5 2026
4 weeks agoAudio Recording of the Earnings call conducted on August 5 2026
4 weeks agoDisclosure under Regulation 30 of SEBI Listing Regulations - Enhancement of manufacturing capacity
4 weeks agoDisclosure under Regulation 30 of SEBI Listing Regulations - Enhancement of manufacturing capacity
4 weeks agoDisclosure under Regulation 30 of SEBI Listing Regulations - Execution of deed of Corporate Guarantee
4 weeks agoDisclosure under Regulation 30 of SEBI Listing Regulations - Execution of deed of Corporate Guarantee
4 weeks agoInvestor Presentation on the Financial Results of the Company for the quarter ended June 30 2026
4 weeks agoInvestor Presentation on the Financial Results of the Company for the quarter ended June 30 2026
4 weeks agoPress Release on the Financial Results of the Company for the quarter ended June 30 2026
4 weeks agoPress Release on the Financial Results of the Company for the quarter ended June 30 2026
4 weeks agoUnaudited Financial Results of the Company for the quarter ended June 30 2026
4 weeks agoUnaudited Financial Results of the Company for the quarter ended June 30 2026
4 weeks agoUnaudited Financial Results of the Company for the quarter ended June 30 2026
4 weeks agoUnaudited Financial Results of the Company for the quarter ended June 30 2026
4 weeks agoVoting Results Scrutinizer Report and proceedings of 42nd Annual General Meeting held on August 4 2026
1 month agoVoting Results Scrutinizer Report and proceedings of 42nd Annual General Meeting held on August 4 2026
1 month agoVoting Results Scrutinizer Report and proceeding of 42nd Annual General Meeting held on August 4 2026
1 month agoVoting Results Scrutinizer Report and proceeding of 42nd Annual General Meeting held on August 4 2026
1 month agoIntimation under Regulation 30 of SEBI Listing Regulations
1 month agoIntimation under Regulation 30 of SEBI Listing Regulations
1 month agoQ1FY27 Earnings Call Intimation
1 month agoQ1FY27 Earnings Call Intimation
1 month agoNeuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2026
1 month agoNeuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2026
1 month agoIntimation of Loss of Share Certificate(s)
1 month agoIntimation of Loss of Share Certificate(s)
1 month agoAnnouncement under Regulation 30 (LODR) - Credit Rating
1 month agoAnnouncement under Regulation 30 (LODR) - Credit Rating
1 month agoNewspaper Publication regarding dispatch of notice of 42nd Annual General Meeting and Integrated Annual Report for FY 2025-26
1 month agoNewspaper Publication regarding dispatch of notice of 42nd Annual General Meeting and Integrated Annual Report for FY 2025-26
1 month agoLetter to the Shareholder of the Company in relation to the Notice of 42nd Annual General Meeting and Integrated Annual Report of the Company for FY 2025-26
1 month agoLetter to the Shareholder of the Company in relation to the Notice of 42nd Annual General Meeting and Integrated Annual Report of the Company for FY 2025-26
1 month agoBusiness Responsibility and Sustainability Report for FY 2025-26
1 month agoBusiness Responsibility and Sustainability Report for FY 2025-26
1 month agoNotice of 42nd Annual General Meeting and Integrated Annual Report FY 2026
1 month agoNotice of 42nd Annual General Meeting and Integrated Annual Report FY 2026
1 month agoConcalls & investor presentations
Aug 2026
May 2026
Feb 2026
Nov 2025
ConcallPresentation
Jul 2025
May 2025
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
Aug 2024
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
Aug 2023
May 2023
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
Aug 2022
May 2022
Feb 2022
Oct 2021
Aug 2021
May 2021
Feb 2021
Nov 2020
Corporate Actions
Date
Type
Details
2026-07-24
Dividend
34.0
2025-07-18
Dividend
12.0
2024-07-12
Dividend
14.0
2023-07-11
Dividend
10.0
2022-07-14
Dividend
5.0
2021-06-29
Dividend
3.0
2020-11-10
Dividend
2.0
2020-02-18
Dividend
2.0
2019-06-27
Dividend
1.2
2016-08-04
Dividend
2.0
2015-08-06
Dividend
1.5
2014-08-13
Rights
4:25;204.0 (Rights ratio;Offer price)
2014-06-16
Dividend
3.0
2013-07-24
Dividend
1.2
2012-03-21
Rights
5:12;45.0 (Rights ratio;Offer price)
Company details
Registered office
11th Floor (5th Office Level) Phoenix I V Y Building, Plot No.573 A- I I I Road No. 82, Jubilee Hills Hyderabad Telangana PIN: 500033 Tel No: 040-67611600 / 67611700 Fax No: 040-30211602 Email: [email protected] Internet: www.neulandlabs.com
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Sarada Bhamidipati, Company Secretary & Compliance Officer
Davuluri Rama Mohan Rao, Chairman
Davuluri Sucheth Rao, Vice Chairman
Davuluri Saharsh Rao, Managing Director & Chief Executive Officer
Homi Rustam Khusrokhan, Non Executive Independent Director
Prasad Raghava Menon, Non Executive Independent Director
Sugata Sircar, Non Executive Independent Director
Pallavi Joshi Bakhru, Non Executive Independent Director
Ravi Shankar Gopinath, Non Executive Independent Director
Mauricio Futran, Non Executive Director
Details
BSE 524558
NSE NEULANDLAB
ISIN INE794A01010